多发性骨髓瘤:2024年关于诊断,风险分层和管理的更新
1Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
American journal of hematology
|June 29, 2024
概括
多发性骨髓瘤是一种血液性恶性瘤,通过特定的标准来诊断,包括骨髓等离子细胞和骨髓定义事件. 治疗策略是根据风险调整的,从诱导疗法和移植到维护和复发管理.
科学领域:
- 血液瘤学 血液瘤学
- 临床血液学 临床血液学
背景情况:
- 多发性骨髓瘤约占所有血液恶性瘤的10%.
- 准确的诊断和风险分层对于有效管理至关重要.
研究的目的:
- 概述多发性骨髓瘤的诊断标准.
- 描述风险分层方法.
- 详细介绍基于风险和疾病状况的当前治疗方法.
主要方法:
- 诊断依赖于克隆骨髓血细胞或血细胞瘤加上骨髓瘤定义事件 (MDEs),就像CRAB标准一样.
- 高风险特征包括特定的遗传异常 (例如,del{17p},t{4;14)) 和它们的组合 (双击,三击骨髓瘤).
- 治疗策略包括诱导疗法 (如VRd),自身干细胞移植 (ASCT),维持疗法和复发性疾病的管理.
主要成果:
- 风险分层识别标准和高风险多发性骨髓瘤,指导治疗强度.
- 用VRd进行诱导疗法,然后进行ASCT,对于可接受移植的患者来说是标准的.
- 维持疗法 (利那利多米德或博特佐米布加利那利多米德) 对于持续缓解至关重要.
- 复发性疾病管理包括三重疗法,CAR-T细胞疗法或双特异性抗体.
结论:
- 风险适应性治疗对于优化多发性骨髓瘤的结果至关重要.
- 目前的治疗模式整合了诱导,移植,维护和救援疗法.
- 像CAR-T和双特异性抗体这样的新兴疗法为复发性多发性髓瘤提供了新的选择.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.1K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.4K
相关概念视频
01:27Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
01:21Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K